- Report
- June 2022
- 220 Pages
Global
From €3387EUR$3,450USD£2,817GBP
€4663EUR$4,750USD£3,878GBP
- Report
- January 2022
- 60 Pages
Global
From €2714EUR$2,765USD£2,257GBP
€3878EUR$3,950USD£3,225GBP
- Report
- November 2020
- 450 Pages
Global
From €4810EUR$4,900USD£4,001GBP
- Report
- September 2020
- 700 Pages
Global
From €4810EUR$4,900USD£4,001GBP
- Clinical Trials
- January 2020
- 1140 Pages
Global
From €2945EUR$3,000USD£2,449GBP
- Report
- April 2019
- 93 Pages
Global
From €2712EUR$2,763USD£2,255GBP
€3191EUR$3,250USD£2,653GBP
- Report
- March 2018
- 102 Pages
Global
From €2295EUR$2,338USD£1,908GBP
€2700EUR$2,750USD£2,245GBP
- Report
- October 2021
- 82 Pages
Global
From €3780EUR$3,850USD£3,143GBP
- Report
- October 2021
- 68 Pages
Global
From €3780EUR$3,850USD£3,143GBP
- Report
- October 2021
- 110 Pages
Global
From €6725EUR$6,850USD£5,593GBP
- Newsletter
- November 2024
- 12 Pages
China
From €196EUR$200USD£163GBP
- Report
- August 2024
- 272 Pages
China
From €3927EUR$4,000USD£3,266GBP
- Report
- August 2024
- 88 Pages
China
From €1767EUR$1,800USD£1,470GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €344EUR$350USD£286GBP
€491EUR$500USD£408GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €344EUR$350USD£286GBP
€491EUR$500USD£408GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €344EUR$350USD£286GBP
€491EUR$500USD£408GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €344EUR$350USD£286GBP
€491EUR$500USD£408GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €344EUR$350USD£286GBP
€491EUR$500USD£408GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €344EUR$350USD£286GBP
€491EUR$500USD£408GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more